TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003
TCL Archive Carter In Last Budget Asks Four Percent Increase For NCI, But Then Seeks $13.5 Million Rescission January 23, 1981